A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa® Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer’s Disease Already Receiving Donepezil (ROMEO-AD)
Han Jo Kim(University of North Carolina at Chapel Hill), S. Duke Han(LAC+USC Medical Center), Byeong C. Kim(Chonnam National University Hospital), Jee Hyang Jeong(Ewha Womans University), Bora Yoon(Konyang University), So Young Moon(Ajou University), Kee Hyung Park(Deleted Institution), Hyun Jeong Han(Kyungdong University), Eun‐Joo Kim(Pusan National University Hospital), Dong Won Yang(St. Mary's Hospital), Seong Hye Choi(Inha University), YongSoo Shim(The Catholic University of Korea St. Vincent's Hospital)
Cited by 6
Related Papers
World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia
|Alzheimer s & Dementia|2020|516
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease
|European Journal of Nuclear Medicine and Molecular Imaging|2008|277
A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma
|PLoS Medicine|2010|251
Endovascular Treatment and the Outcomes of Atherosclerotic Intracranial Stenosis in Patients With Hyperacute Stroke
|Neurosurgery|2015|179
Ensembles of Patch-Based Classifiers for Diagnosis of Alzheimer Diseases
|IEEE Access|2019|150